- Cancer Types
Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Cancer A to Z - Cancer Treatment
Cancer Treatment
Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
- Risk and Prevention
- Cancer Drugs
- Support
Support
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
- Healthcare Professionals
- Clinical Trials
My Patient Treatment Binder
OncoLink Blogs
What's My Cancer Risk?
OncoPilot: Navigating Your Cancer Journey
Community Events Calendar
OncoLink eNews
Abramson Cancer CenterPreconference Corporate Symposium Sponsored by Amgen Inc.
43rd Conference of The American Society of Hematology
|
Alternative Targets for Immunotherapy: Targeting CD22 With Monoclonal Antibodies for the Treatment of Non-Hodgkin?s Lymphoma
Presenter: John P. Leonard, MD Affiliation: Cornell University While mortality rates for patients with prostate cancer or breast cancer are decreasing, death rates for patients with non-Hodgkin?s lymphoma continue to rise. Accordingly, the... |
|
|
Clinical Implications of Stem Cell Plasticity: Repair of the Infarcted Heart by Cytokine-Mobilized Bone Marrow Stem Cells
Presenter: Donald Orlic, PhD Stem cell plasticity refers to the recently discovered ability of bone marrow stem cells (BMSCs) to generate non-hematopoietic cell types, such as epithelial, skeletal muscle, bone, liver, and neural cells. Dr. Orlic... |
|
|
Cytokine-Based Approaches for Reducing the Impact of Chemoradiotherapy-Induced Mucositis and Graft-Versus-Host Disease
Presenter: Bruce Blazar, MD Stem cell plasticity refers to the recently discovered ability of bone marrow stem cells (BMSCs) to generate non-hematopoietic cell types, such as epithelial, skeletal muscle, bone, liver, and neural cells. Dr. Orlic... |
|
|
Improving the Management of Chemotherapy-Induced Neutropenia: Progress in Developing Once-per-Cycle Cytokine Support
Presenter: Jeffrey Crawford, MD Chemotherapy induced neutropenia is one of the primary dose limiting toxicities of cancer treatment, putting patients at risk of infection and frequently leading to treatment interruptions and sub-optimal chemotherapy... |
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
